# KYNAMRO
> **NDA203568** · New Drug Application · Sponsor: KASTLE THERAPS LLC · Approved 2013-01-29
## Drug
- **FDA Application Number:** NDA203568
- **Application type:** New Drug Application
- **Brand name:** KYNAMRO
- **Generic name:** Mipomersen Sodium
- **Active ingredients:** MIPOMERSEN SODIUM
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** KASTLE THERAPS LLC
- **First approval:** 2013-01-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203568)
---
*AI Analytics · CC0 1.0*